Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$22.9M
-21.5% from 2023
Prescriptions
437K
$52.27 per claim
Patients
115K
68,332 prescribers
Total spending, 2024
$22.9M
$198.62 per patient
Medicare prescription drug plans paid $22.9M for Amlodipine-Valsartan in 2024, for 437,240 prescriptions and refills to 115,067 patients (down 21.5% from 2023). The average cost per claim was $52.27.
Texas had the highest Medicare cost for Amlodipine-Valsartan in 2024: $2.2M for 42,003 claims, followed by New York ($2.0M).
Victoria J Gordon, family practice in Orange, TX, had the highest Medicare cost for Amlodipine-Valsartan in 2024: 303 claims costing $45K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Victoria J Gordon Orange, TX | Family Practice | 303 | 90 | $45K |
| Edward G Carlos Mobile, AL | Internal Medicine | 414 | 117 | $30K |
| Rattanjit S Kohli |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 54,017 | 323,564 | 84,210 | $23.2M |
| 2023 | 60,074 | 368,225 | 97,440 | $29.1M |
| 2024 | 68,332 | 437,240 | 115,067 | $22.9M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 612 |
| 158 |
| $27K |
| Jose Bossbaly Philadelphia, PA | Internal Medicine | 147 | 36 | $22K |
| Jerry B Williams Sheffield, AL | Cardiology | 289 | 90 | $20K |
| Mohamed H Khan Redding, CA | Interventional Cardiology | 323 | 135 | $20K |
| Randall Suzuka Haleiwa, HI | Family Practice | 248 | 79 | $20K |
| Angela N Grasser Kerman, CA | Family Practice | 396 | 114 | $18K |
| Devell R Young Albany, GA | Internal Medicine | 299 | 81 | $18K |
| Padiwath C Ung Pinehurst, NC | Internal Medicine | 232 | 63 | $17K |
| Philip B Mellen Gulfport, MS | Internal Medicine | 281 | 60 | $16K |
| Connie K Nguyen Westminster, CA | Family Practice | 283 | 61 | $15K |
| Amit N Patel Baton Rouge, LA | Interventional Cardiology | 405 | 135 | $15K |
| Yuqing Zhang Flushing, NY | Family Practice | 753 | 107 | $14K |
| Michael W Milbourne Glenside, PA | Cardiology | 179 | 59 | $14K |
| Joann Nguyen San Jose, CA | Family Practice | 337 | 83 | $14K |
| Samantha Alonso Brooklyn, NY | Internal Medicine | 321 | 102 | $14K |
| Jeffrey J Lee Bronx, NY | Internal Medicine | 360 | 111 | $14K |
| Matthew Kittle Ypsilanti, MI | Family Practice | 100 | 26 | $13K |
| Kevin M Taylor Ypsilanti, MI | Internal Medicine | 139 | 39 | $13K |
| Jason S McKenzie Sparks, NV | Family Practice | 225 | 54 | $13K |
| Anthony D Horton Sheffield, AL | Family Practice | 184 | 52 | $13K |
| Matthew H Bucher Frankfort, KY | Family Practice | 260 | 69 | $13K |
| Max E Mercado Philadelphia, PA | Internal Medicine | 116 | 24 | $13K |
| Hima B Punukollu Brooklyn, NY | Internal Medicine | 269 | 79 | $13K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Mylan VTRS | 219,209 | $11.1M |
| Alembic Pharmac | 135,583 | $7.3M |
| Avet Pharmaceut | 81,517 | $4.4M |
| Aurobindo Pharm AUROPHARMA.NS | 997 | $44K |
| Gavis/Lupin | 42 | $2,297 |